Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

28.44 +2.15 (+8.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,694,748
Open	27.51
Bid (Size)	28.28 (400)
Ask (Size)	28.50 (2,000)
Prev. Close	26.29
Today's Range	26.89 - 28.47
52wk Range	18.92 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition

February 06, 2026

Eli Lilly and Company (NYSE: LLY) has officially entered the "trillion-dollar club" with a roar, issuing a blockbuster financial guidance for 2026 that projects revenue between $80 billion and $83...

Via MarketMinute

The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts

February 05, 2026

In a dramatic week for the pharmaceutical sector, a stark rift has opened between the two undisputed titans of the weight-loss drug market. On February 4, 2026, Eli Lilly (NYSE:LLY) reported a...

Via MarketMinute

Performance

YTD	-19.7%	-19.7%
1 Month	-12.2%	-12.2%
3 Month	-22.7%	-22.7%
6 Month	-24.9%	-24.9%
1 Year	-9.6%	-9.6%

More News

The Smartest Growth Stock to Buy With $30 Right Now ↗

February 03, 2026

Via The Motley Fool

VKTX Shares Garner Retail Attention Ahead Of Q4 Earnings Report ↗

February 03, 2026

Via Stocktwits

VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗

January 14, 2026

Via Stocktwits

2 Biotech Stocks Set to Rebound in 2026 ↗

January 27, 2026

Via The Motley Fool

Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗

January 26, 2026

Via The Motley Fool

3 Growth Stocks to Invest $1,000 in Right Now ↗

January 24, 2026

Via The Motley Fool

The Best Stocks to Invest $40 in to Start the New Year Off Right ↗

January 24, 2026

Via The Motley Fool

Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly

January 23, 2026

Via Finterra

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗

January 23, 2026

Via The Motley Fool

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

January 22, 2026

Via MarketMinute

2 Bargain Stocks You Can Buy for Less Than $100 Right Now ↗

January 21, 2026

Via The Motley Fool

1 Stock That Could Soar by 175%, According to Wall Street ↗

January 21, 2026

Via The Motley Fool

What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗

January 20, 2026

Via The Motley Fool

3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗

January 20, 2026

Via MarketBeat

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins

January 19, 2026

Via Finterra

The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019

January 12, 2026

Via MarketMinute

What Investors Should Know About a Viking Therapeutics Insider's $2 Million Stock Sale ↗

January 11, 2026

Via The Motley Fool

The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)

January 09, 2026

Via PredictStreet

The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance

January 07, 2026

Via MarketMinute

The Trillion-Dollar Treatment: Eli Lilly Solidifies Dominance as Obesity Drug Boom Enters New Era

January 07, 2026

Via MarketMinute

Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears

January 07, 2026

Via MarketMinute

The Trillion-Dollar Pivot: Eli Lilly Unleashes Volume-Led Strategy to Cement Obesity Market Dominance in 2026

January 06, 2026

Via MarketMinute

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 28.44

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 02/06/26 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.83B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.